vimarsana.com

Page 62 - சர்வதேச கணக்குவைப்பு முறை தரநிலைகள் பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |Jardine Strategic Announcements | Jardine Strategic: 2020 Preliminary Announcement of Results

    · Underlying net profit attributable to shareholders down 35% to US$1,094 million and underlying earnings per share down 34% to US$1.96 · Southeast Asian businesses and Mandarin Oriental severely impacted by the pandemic, but resilience in Hongkong Land, Dairy Farm, Jardine Pacific and Jardine Motors · Continued investment for the long-term exemplified by US$4.5 billion investment by Hongkong Land in West Bund in Shanghai 2020 has brought major challenges to our teams and businesses, but also demonstrated once again the Group s ability to adapt and thrive as our businesses accelerated the pace at which they adopt technology and embraced digital ways of working.  High levels of uncertainty remain in respect of this year, however, given the continuing impact of the pandemic.  The Group s performance in the first part of 2021 is expected to be affected in particular by the continuing headwinds faced by ou

Bausch Health Announces CFO Succession Plan

Bausch Health Announces CFO Succession Plan News provided by Share this article Herendeen Will Remain at Bausch Health as Advisor to the Chairman and CEO LAVAL, Quebec, March 11, 2021 /PRNewswire/ Bausch Health Companies Inc. (NYSE/TSX: BHC) ( Bausch Health or the Company ) today announced that Chief Financial Officer (CFO) Paul S. Herendeen will be appointed to the newly created role of Advisor to the chairman and chief executive officer (CEO) of Bausch Health, effective June 1, 2021. Mr. Herendeen will be succeeded as CFO by Sam Eldessouky, senior vice president, controller and chief accounting officer of Bausch Health. Mr. Herendeen will remain an executive vice president (EVP) and Section 16 officer of Bausch Health.

Investegate |Tremor International Announcements | Tremor International: Full Year Audited 2020 Results

o  Programmatic 1 n et revenue increased by 30% to $161.6 million (2019: $124.2million) offset by an anticipated decrease of 43% in Performance 2 activity o  Total net revenue increased by 12% to $184.3 million (2019: $164.0 million) with 88% of net revenues generated from Programmatic activities compared to 76% in 2019, and 91% in Q4 2020 - see table below · Record H2 adjusted EBITDA 3 of $58.7 million, up 51% vs. H2 2019 o  Full year 2020 adjusted EBITDA of $60.5 million (2019: $60.4 million) impacted by Covid-19 related and industry-wide headwinds across global advertising markets in H1 2020 o  I ncrease in Programmatic activities, mainly attributable to revenue growth in Connected TV ( CTV ), self-serve platform as well as the DSP offerings in private marketplaces. This was offset by the anticipated decrease in Performance activities

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.